Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Early results from first clinical study of JNJ-26854165 reported

Oct. 27, 2008

NMS and Genentech sign collaboration agreement for antibody drug conjugates in cancer

Oct. 24, 2008

Activity seen with OSI-930 in phase I study in solid tumor patients

Oct. 24, 2008

Bendamustine-rituximab combination active in relapsed mantle cell and indolent B-cell lymphoma

Oct. 24, 2008

Preliminary phase II data on neratinib in non-small cell lung cancer presented

Oct. 23, 2008

Preclinical profile of anticancer agent UNBS-5162 described

Oct. 23, 2008

FDA approves orphan drug status for new cancer drug for children

Oct. 23, 2008

4SC reports results from phase I trial with cancer drug candidate 4SC-201

Oct. 22, 2008

Biotec Pharmacon presents update on development of SBG

Oct. 22, 2008

Insights into the mechanism of action of maspin

Oct. 22, 2008

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...